Coloplast As ADR (CLPBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 993,506 | 958,922 | 953,906 | 909,315 | 892,379 |
| Cost of Goods | 322,799 | 307,070 | 303,529 | 305,176 | 304,619 |
| Gross Profit | 670,706 | 651,851 | 650,378 | 604,139 | 587,760 |
| Operating Expenses | 406,859 | 393,919 | 389,976 | 363,463 | 337,963 |
| Operating Income | 264,646 | 258,003 | 260,931 | 240,852 | 250,415 |
| Interest Expense | 34,199 | 29,266 | 48,374 | 30,220 | 20,600 |
| Other Income | 4,906 | 5,242 | 11,841 | 11,675 | 5,406 |
| Pre-tax Income | 235,353 | 233,979 | 224,398 | 222,307 | 235,221 |
| Income Tax | 51,515 | 51,688 | 49,385 | 43,436 | 49,382 |
| Net Income Continuous | 183,838 | 182,291 | 175,013 | 178,871 | 185,839 |
| Net Income | $183,838 | $182,291 | $175,013 | $178,870 | $185,839 |
| EPS Basic Total Ops | 0.08 | 0.08 | 0.08 | 0.08 | 0.09 |
| EPS Basic Continuous Ops | 0.08 | 0.08 | 0.08 | 0.08 | 0.09 |
| EPS Diluted Total Ops | 0.08 | 0.08 | 0.08 | 0.08 | 0.09 |
| EPS Diluted Continuous Ops | 0.08 | 0.08 | 0.08 | 0.08 | 0.09 |
| EPS Diluted Before Non-Recurring Items | 0.08 | 0.08 | 0.08 | N/A | N/A |
| EBITDA(a) | $311,162 | $304,819 | $305,406 | $278,435 | $289,898 |